SIG Greatest Hits: TLM 2025-Hepatitis C SIG: Behind Bars, Not Beyond Reach Tackling HCV in Correctional Settings

Hepatitis C SIG: Behind Bars, Not Beyond Reach Tackling HCV in Correctional Settings

Video Transcription

Video Summary

Dr. Matthew Akiyama highlights the critical role of carceral settings—jails, prisons, and community corrections—in hepatitis C (HCV) elimination efforts. HCV prevalence is notably higher in these populations due to criminalization of substance use, systemic inequalities, and frequent incarceration. Jails, where 95% of people return to the community, present unique opportunities for testing and treatment, especially with innovations like point-of-care RNA testing enabling rapid, effective intervention. While many face barriers to healthcare engagement, programs in New York City jails and Washington prisons demonstrate successful treatment cascades and reductions in viral prevalence. Peer education and simplified treatment protocols further improve uptake and outcomes. However, challenges remain, including short jail stays and post-release reinfection risks. Akiyama stresses the need for political will, resources, and community partnerships to integrate comprehensive HCV care across all carceral touchpoints, underscoring carceral health as essential public health and a vital part of national elimination strategies.

Asset Subtitle

Talk delivered by Dr. Matthew Akiyama. Talk part of the Hepatitis C Management in Unique and Key Populations session.

Keywords

Hepatitis C elimination

carceral settings

jails and prisons

point-of-care RNA testing

peer education